REG - Halma PLC - Acquisition

HalmaAnnouncement

19/11/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211119:nRSS8859Sa&default-theme=true

RNS Number : 8859S  Halma PLC  19 November 2021

Halma plc

('Halma' or the 'Group')

Acquisition

Halma, the global group of life-saving technology companies focused on growing
a safer, cleaner and healthier future for everyone every day, today announces
that it has acquired Infinite Leap, Inc. (Infinite Leap) for its Medical
sector business, CenTrak, which provides real-time location services for
healthcare facilities.

Infinite Leap is a healthcare consulting and services provider for real-time
location technologies, based in Fargo, North Dakota, USA, which is also
developing unique new hardware and software solutions for applications
adjacent to CenTrak's core market. The initial cash consideration is US$30m
(approximately £22m), on a cash and debt free basis, which will be funded
from Halma's existing facilities. Additional earn-out considerations are
payable in cash, based on growth targets in each of the two financial years to
30 September 2023, up to an aggregate maximum of US$17m (approximately £13m).
Infinite Leap's unaudited revenue for the 12 months to 31 March 2021 was
US$6.8m (approximately £5m) (see "Further information on Infinite Leap" below
for further details).

Andrew Williams, Group Chief Executive of Halma, commented:

"Infinite Leap is an exciting acquisition that will enhance CenTrak's
capabilities as an end-to-end enterprise solutions provider for healthcare
organisations. It will enable CenTrak to broaden its services, solutions and
technologies to support the growing needs of healthcare providers,
particularly larger organisations with networks of healthcare facilities, in
the post-pandemic world."

For further information, please contact:

Halma plc

Andrew Williams, Group Chief
Executive
+44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer

Charles King, Head of Investor
Relations
+44 (0) 7776 685948

Clayton Hirst, Director of Corporate Affairs
                     +44 (0) 7384 796 013

MHP Communications

Andrew Jaques / Rachel Farrington
                           +44 (0)20 3128 8572

A copy of this announcement, together with other information about Halma, is
available at www.halma.com.

About Halma

Halma is a global group of life-saving technology companies, focused on
growing a safer, cleaner, healthier future for everyone, every day.

Its purpose defines the three broad market areas where it operates:

·    Safety: protecting life as populations grow and protecting worker
safety.

·    Environment: improving food and water quality, and monitoring air
pollution.

·    Health: meeting rising healthcare demand as growing populations age
and lifestyles change.

It employs over 7,000 people in more than 20 countries, with major operations
in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on
the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100
index.

In January 2021, Halma was named Britain's Most Admired Company by
Management Today.

Further information on Infinite Leap

Infinite Leap, based in Fargo, North Dakota, USA, is a healthcare consulting
and services provider for real-time location technologies. The company
delivers industry leading patient and staff workflow software as well as
end-to-end services - from solution design and business planning to
deployment, training, 24/7 support, and managed services. Infinite Leap has
helped healthcare providers successfully implement hundreds of projects and
dozens of unique use cases, including patient flow optimisation, asset
management, environmental monitoring, staff safety, wayfinding, and more.

Infinite Leap's unaudited revenue for the 12 months to 31 March 2021 of
US$6.8m (approximately £5m) was principally derived from its Enterprise
Solutions business, whose growth rate and return on sales are above Halma's
target ranges. The business also includes a start-up, Prompt Health, which is
developing a lower-cost hardware and software solution for use the ambulatory
(out-patient) sector. Prompt Health is currently loss-making and is expected
to become profitable over the next 2 to 3 years.

More information on Infinite Leap is available at www.infiniteleap.net.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACQBPBFTMTABBLB